FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
The FDA reviewed the drug under its program that promises ultra-fast reviews for promising medications that serve the public interest
· 7/18/2026, 2:29:54 PM· 2 min read
The FDA reviewed the drug under its program that promises ultra-fast reviews for promising medications that serve the public interest
Read original story →
